Need professional-grade analysis? Visit stockanalysis.com
$19.99B
26.16
11,000
N/A
DexCom, Inc. (DC4) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at EUR51.80, down 0.77% from the previous close.
Over the past year, DC4 has traded between a low of EUR49.70 and a high of EUR77.99. The stock has lost 31.5% over this period. It is currently 33.6% below its 52-week high.
DexCom, Inc. has a market capitalization of $19.99B, with a price-to-earnings ratio of 26.16.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Side-by-side comparison against top Healthcare peers.